Pharvaris (PHVS) Property, Plant & Equipment (Net) (2019 - 2026)

Pharvaris (PHVS) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 642,333.36
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 31.48 Mn
10 Pharvaris 2.22 Bn 1.94 Bn - 753,022.43

Historic Data

Download Data
DateValue
Mar 31, 2026 753,022.43
Mar 31, 2026 753,022.43
Dec 31, 2025 747,863.04
Dec 31, 2025 747,863.04
Sep 30, 2025 806,842.08
Sep 30, 2025 806,842.08
Jun 30, 2025 815,004.18
Jun 30, 2025 815,004.18
Mar 31, 2025 825,381.11
Mar 31, 2025 825,381.11
Dec 31, 2024 712,753.13
Dec 31, 2024 712,753.13
Sep 30, 2024 596,661.56
Sep 30, 2024 596,661.56
Jun 30, 2024 278,430.36
Jun 30, 2024 278,430.36
Mar 31, 2024 257,992.45
Mar 31, 2024 257,992.45
Dec 31, 2023 240,664.09
Dec 31, 2023 240,664.09